Feingold Jay
SEC CIK 1885838 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PYXS | Pyxis Oncology, Inc. | Chief Medical Off | 730.3K | — | — | 5 | 2021-10-07 | 2023-03-24 |
Most active insiders at PYXS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dupont Jakob | Dir | — | $107.1K |
| 2 | Wadhane Jitendra | Prin Fin, Acct Off | — | — |
Feingold Jay made no open-market trades at PYXS in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-28 | 2023-03-24 | PYXS | Pyxis Oncology, Inc. | Feingold Jay | Chief Medical Off | A - Grant | $0.00 | +209.8K | 730.3K | +40% | $0 |
| 2023-01-03 | 2023-01-03 | PYXS | Pyxis Oncology, Inc. | Feingold Jay | Chief Medical Off | A - Grant | $0.00 | +53.9K | 520.5K | +12% | $0 | |
| 2022-04-15 | 2022-04-14 | PYXS | Pyxis Oncology, Inc. | Feingold Jay | Chief Medical Off | A - Grant | $0.00 | +115.9K | 466.6K | +33% | $0 | |
| 2022-04-04 | 2022-03-31 | PYXS | Pyxis Oncology, Inc. | Feingold Jay | Chief Medical Off | A - Grant | $0.00 | +306.9K | 350.7K | +702% | $0 | |
| D | 2021-10-12 | 2021-10-07 | PYXS | Pyxis Oncology, Inc. | Feingold Jay | Chief Medical Off | A - Grant | $0.00 | +43.8K | 43.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations